New loteprednol formulation approved for postop inflammation, pain management
- Posted on: Feb 27 2019
- Leave a response
Bausch + Lomb’s new formulation of loteprednol etabonate ophthalmic gel, Lotemax SM 0.38%, has been cleared by the FDA for postoperative pain and inflammation.
Source: AAO
Posted in: Uncategorized
